Author: Timothy Okechukwu Umahi, University of Manchester
Published: December 25, 2011
Abstract: This article advocates effective corporate social responsibility (CSR) for multinational pharmaceutical companies in research and development of drug needs of developing countries. It acknowledges access to medicines as a fundamental right in the global public domain, which leaves the option of the associated problem as a moral responsibility for multinational pharmaceutical companies. The article suggests that access to medicines would be enhanced if the pharmaceutical companies become responsible in their pricing, patents, testing, research and development, joint public private initiative and appropriate use of drugs.
Related Regions and Countries: Nigeria
Keywords: Access to medicines, corporate social responsibility, developing countries, ethical, globalisation